Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (261-270 of 404) with videos related to

Pageof 41
Sort By:
The Medical Journal of Australia|August 29, 2002
Factors associated with severity of hepatic fibrosis in people with chronic hepatitis C infectionMark Danta, Gregory J Dore, Lisa Hennessy, et al.
Journal of Hepatology|September 10, 2014
Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatmentEsther J Aspinall, Sharon J Hutchinson, Naveed Z Janjua, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDavid A Sheridan, Behzad Hajarizadeh, Fiona I Fenwick, et al.
Journal of Viral Hepatitis|November 25, 2016
A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategiesSofia R Bartlett, Joel O Wertheim, Rowena A Bull, et al.
Antiviral Therapy|February 12, 2016
Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studiesMarianne Martinello, Margaret Hellard, David Shaw, et al.
The International Journal on Drug Policy|August 24, 2021
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohortJoanne M Carson, Behzad Hajarizadeh, Josh Hanson, et al.
Viruses|November 11, 2022
Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot StudyAnna Conway, Phillip Read, Rosie Gilliver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2021
Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage StudyHeather Valerio, Maryam Alavi, Matthew Law, et al.
Open Forum Infectious Diseases|December 18, 2024
Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)Marianne Martinello, Joanne M Carson, Jeffrey J Post, et al.
Antiviral Therapy|March 31, 2011
Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patientsCristina Baleriola, William D Rawlinson, Gregory J Dore, et al.
Pageof 41

Showing results (261-270 of 404) with videos related to

Sort By:
Pageof 41
The Medical Journal of Australia|August 29, 2002
Factors associated with severity of hepatic fibrosis in people with chronic hepatitis C infectionMark Danta, Gregory J Dore, Lisa Hennessy, et al.
Journal of Hepatology|September 10, 2014
Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatmentEsther J Aspinall, Sharon J Hutchinson, Naveed Z Janjua, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDavid A Sheridan, Behzad Hajarizadeh, Fiona I Fenwick, et al.
Journal of Viral Hepatitis|November 25, 2016
A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategiesSofia R Bartlett, Joel O Wertheim, Rowena A Bull, et al.
Antiviral Therapy|February 12, 2016
Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studiesMarianne Martinello, Margaret Hellard, David Shaw, et al.
The International Journal on Drug Policy|August 24, 2021
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohortJoanne M Carson, Behzad Hajarizadeh, Josh Hanson, et al.
Viruses|November 11, 2022
Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot StudyAnna Conway, Phillip Read, Rosie Gilliver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2021
Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage StudyHeather Valerio, Maryam Alavi, Matthew Law, et al.
Open Forum Infectious Diseases|December 18, 2024
Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)Marianne Martinello, Joanne M Carson, Jeffrey J Post, et al.
Antiviral Therapy|March 31, 2011
Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patientsCristina Baleriola, William D Rawlinson, Gregory J Dore, et al.
Pageof 41